orforglipron weight maintenance
Orforglipron vs Semaglutide: Will Prescription Weight Loss Stick?
In the ATTAIN-MAINTAIN phase 3b trial, patients who switched from tirzepatide to oral orforglipron kept an average 10.5% weight loss over 16 weeks. Orforglipron therefore appears to preserve the gains of injectable GLP-1 therapy better than stopping semaglutide, offering a practical maintenance option. Medical Disclaimer: This article is for